03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Makoto Fukuda: no photograph is held, so the academic plate is shown instead.
Academic
Makoto Fukuda
Pathophysiologist at Baylor College of Medicine
5
1
0
0
0
3
0
0
0
Mar 2026AprMayJuneJulyAugSeptOctNovto date
9
press citations on 1 topic since 26 Mar 2026 · last quoted 17 Aug 2026
02 Quoted on · 1 of 29 topics
Makoto Fukuda: key facts
- Kind of voice
- Academic
- Role
- Pathophysiologist at Baylor College of Medicine
- Quoted on
- Diabetes
- Tracked press citations
- 9
- Most recently quoted
- 17 Aug 2026
- First quoted
- 26 Mar 2026
04 The signal · where Makoto Fukuda sits on diabetes
Ranked 8= of 100 voices quoted in the press on diabetes, level with 1 other on 9 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 6=
Dr. Shivani MisraAcademicClinical Associate Professor in Diabetes; Head of Section for Metabolic Medicine, Imperial College London (Department of Metabolism, Digestion and Reproduction, Faculty of Medicine)12 - 8=Dr Clare HamblingAcademicNHS national clinical director for diabetes and obesity9
- 8=Makoto FukudaAcademicPathophysiologist at Baylor College of Medicine9
- 10=Raj R PatelClinicianPharmacist (posts as Pharmacist Health Raj on TikTok)8
- 10=
Dr Marie SpreckleyAcademicPostdoctoral Researcher and Research Programme Manager, Prevention of Diabetes and Related Metabolic Disorders in High-Risk Groups, MRC Epidemiology Unit / IMS Epidemiology, University of Cambridge8
Showing the leaders and the ranks around 8=, of 100 voices · See every voice on the topic →
05 On the record · press
What Makoto Fukuda has said
By outlet · linked articles
- ladbible.com3
- dailyrecord.co.uk2
- mirror.co.uk2
- aol.co.uk1
- lancs.live1
Where Makoto Fukuda has been quoted
- 01Scientists uncover 'hidden brain effects' of medication taken by millions - AOLaol.co.uk · 17 Aug 2026
- 02Metformin update as scientists explain how it actually worksdailyrecord.co.uk · 17 Aug 2026
- 03Scientists uncover 'brain effects' of medication taken by millionsmirror.co.uk · 17 Aug 2026
- 04Woman on Metformin shares changes she noticed in three weeks as new study finds unexpected benefitladbible.com · 8 Apr 2026
- 05People on metformin may face 'unexpected' effect on brainmirror.co.uk · 27 Mar 2026
- 06Metformin breakthrough as study finds 'unexpected' brain impactlancs.live · 27 Mar 2026
- 07Metformin user shares side effects she noticed as new study shares surprise impact on brainladbible.com · 27 Mar 2026
- 08Metformin drug prescribed to 120 million worldwide found to have surprise impact on brainladbible.com · 26 Mar 2026
- 09Diabetes drug used for over 60 years revealed to unexpectedly affect braindailyrecord.co.uk · 26 Mar 2026
Verbatim
“This discovery changes how we think about metformin. It's not just working in the liver or the gut, it's also acting in the brain.”
“This discovery changes how we think about metformin. It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”
“We found that SF1 neurons are activated when metformin is introduced into the brain, suggesting they're directly involved in the drug's action.”
“It's been widely accepted that metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut.”
“It's been widely accepted that Metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut”
“It's been widely accepted that Metformin lowers blood glucose primarily by reducing glucose output in the liver. Other studies have found that it acts through the gut.”
“These findings open the door to developing new diabetes treatments that directly target this pathway in the brain.”
“These findings open the door to developing new diabetes treatments that directly target this pathway in the brain.”
“This discovery changes how we think about metformin. It's not just working in the liver or the gut, it's also acting in the brain.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.